Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Capellà

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
WHO Regional Publications. European Series|January 1, 1993
Descriptive tools and analysisD Capellà
Medicina Clinica|July 4, 1987
[Drug consumption]J R Laporte, D Capellà
Medicina Clinica|September 24, 1994
[The Spanish drug surveillance system]J R Laporte, D Capellà
Lancet (London, England)|June 6, 1987
Useless drugs are not placebosJ R Laporte, D Capellà
Medicina Clinica|March 18, 1995
[Fulminant liver failure due to bendazac]J R Laporte, D Capellà
Medicina Clinica|November 24, 1990
[Benzodiazepines and insomnia: should they always go together?]J R Laporte, D Capellà
Medicina Clinica|October 13, 1984
[Notification of possible adverse reactions to drugs in medical publications]J R Laporte, D Capellà
European Journal of Clinical Pharmacology|January 1, 1983
Utilization of antihypertensive drugs in certain European countriesD Capellà, M Porta, J R Laporte
European Journal of Clinical Pharmacology|January 1, 1990
Agranulocytosis induced by cinepazideJ R Laporte, D Capellà, J Juan
European Journal of Clinical Pharmacology|September 29, 1999
Fluoxetine-induced hepatitis: why is postmarketing surveillance needed?D Capellà, M Bruguera, A Figueras, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
WHO Regional Publications. European Series|January 1, 1993
Descriptive tools and analysisD Capellà
Medicina Clinica|July 4, 1987
[Drug consumption]J R Laporte, D Capellà
Medicina Clinica|September 24, 1994
[The Spanish drug surveillance system]J R Laporte, D Capellà
Lancet (London, England)|June 6, 1987
Useless drugs are not placebosJ R Laporte, D Capellà
Medicina Clinica|March 18, 1995
[Fulminant liver failure due to bendazac]J R Laporte, D Capellà
Medicina Clinica|November 24, 1990
[Benzodiazepines and insomnia: should they always go together?]J R Laporte, D Capellà
Medicina Clinica|October 13, 1984
[Notification of possible adverse reactions to drugs in medical publications]J R Laporte, D Capellà
European Journal of Clinical Pharmacology|January 1, 1983
Utilization of antihypertensive drugs in certain European countriesD Capellà, M Porta, J R Laporte
European Journal of Clinical Pharmacology|January 1, 1990
Agranulocytosis induced by cinepazideJ R Laporte, D Capellà, J Juan
European Journal of Clinical Pharmacology|September 29, 1999
Fluoxetine-induced hepatitis: why is postmarketing surveillance needed?D Capellà, M Bruguera, A Figueras, et al.
Pageof 4